Form 4 for TELA TELA Bio, Inc.

Accepted 2022-09-15 00:00:00 ET · period of report 2022-09-13 · accession 0001493152-22-025979 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2022-09-15	2022-08-16	TELA	Opaleye Management Inc.	10%	P - Purchase	$8.10	+5,221	120.2K	+5%	+$42.3K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, par value $0.001 per share	2022-08-16	P	A	5,000	$8.10	1,885,000	I By Opaleye, L.P.	—	—	(F3) This transaction was executed in multiple trades at prices ranging from $8.09 to $8.10; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased. (F1) Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
2	Common	Common Stock, par value $0.001 per share	2022-08-16	P	A	221	$8.10	120,217	I By Managed Account	—	—	(F3) This transaction was executed in multiple trades at prices ranging from $8.09 to $8.10; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased. (F2) Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.